Andrei A. Kramerov
Ophthalmology Research Laboratories
Cedars-Sinai Medical Center
Los Angeles
CA 90048
USA
Name/email consistency: high
- Treatment of cultured human astrocytes and vascular endothelial cells with protein kinase CK2 inhibitors induces early changes in cell shape and cytoskeleton. Kramerov, A.A., Golub, A.G., Bdzhola, V.G., Yarmoluk, S.M., Ahmed, K., Bretner, M., Ljubimov, A.V. Mol. Cell. Biochem. (2011)
- Inhibition of protein kinase CK2 suppresses angiogenesis and hematopoietic stem cell recruitment to retinal neovascularization sites. Kramerov, A.A., Saghizadeh, M., Caballero, S., Shaw, L.C., Li Calzi, S., Bretner, M., Montenarh, M., Pinna, L.A., Grant, M.B., Ljubimov, A.V. Mol. Cell. Biochem. (2008)
- Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina. Kramerov, A.A., Saghizadeh, M., Pan, H., Kabosova, A., Montenarh, M., Ahmed, K., Penn, J.S., Chan, C.K., Hinton, D.R., Grant, M.B., Ljubimov, A.V. Am. J. Pathol. (2006)